Prognostic	0	10	O
value	11	16	O
of	17	19	O
p53	20	23	B-Gene_or_gene_product
protein	24	31	O
expression	32	42	O
and	43	46	O
vascular	47	55	B-Gene_or_gene_product
endothelial	56	67	I-Gene_or_gene_product
growth	68	74	I-Gene_or_gene_product
factor	75	81	I-Gene_or_gene_product
expression	82	92	O
in	93	95	O
resected	96	104	O
squamous	105	113	B-Pathological_formation
cell	114	118	I-Pathological_formation
carcinoma	119	128	I-Pathological_formation
of	129	131	O
the	132	135	O
esophagus	136	145	B-Organ
.	145	146	O

The	148	151	O
most	152	156	O
common	157	163	O
genetic	164	171	O
alterations	172	183	O
found	184	189	O
in	190	192	O
a	193	194	O
wide	195	199	O
variety	200	207	O
of	208	210	O
cancers	211	218	B-Pathological_formation
are	219	222	O
p53	223	226	B-Gene_or_gene_product
tumor	227	232	O
suppressor	233	243	O
gene	244	248	O
mutations	249	258	O
.	258	259	O

p53	260	263	B-Gene_or_gene_product
appears	264	271	O
to	272	274	O
be	275	277	O
a	278	279	O
nuclear	280	287	O
transcription	288	301	O
factor	302	308	O
that	309	313	O
plays	314	319	O
a	320	321	O
role	322	326	O
in	327	329	O
the	330	333	O
control	334	341	O
of	342	344	O
cell	345	349	B-Cell
proliferation	350	363	O
,	363	364	O
apoptosis	365	374	O
,	374	375	O
and	376	379	O
the	380	383	O
maintenance	384	395	O
of	396	398	O
genetic	399	406	O
stability	407	416	O
.	416	417	O

Angiogenesis	418	430	O
is	431	433	O
a	434	435	O
critical	436	444	O
process	445	452	O
in	453	455	O
solid	456	461	B-Pathological_formation
tumor	462	467	I-Pathological_formation
growth	468	474	O
and	475	478	O
metastasis	479	489	O
.	489	490	O

Vascular	491	499	B-Gene_or_gene_product
endothelial	500	511	I-Gene_or_gene_product
growth	512	518	I-Gene_or_gene_product
factor	519	525	I-Gene_or_gene_product
(	526	527	O
VEGF	527	531	B-Gene_or_gene_product
)	531	532	O
,	532	533	O
a	534	535	O
recently	536	544	O
identified	545	555	O
growth	556	562	O
factor	563	569	O
with	570	574	O
significant	575	586	O
angiogenic	587	597	O
properties	598	608	O
,	608	609	O
may	610	613	O
be	614	616	O
a	617	618	O
major	619	624	O
tumor	625	630	B-Pathological_formation
angiogenesis	631	643	O
regulator	644	653	O
.	653	654	O

Few	655	658	O
studies	659	666	O
have	667	671	O
investigated	672	684	O
the	685	688	O
association	689	700	O
between	701	708	O
p53	709	712	B-Gene_or_gene_product
and	713	716	O
VEGF	717	721	B-Gene_or_gene_product
expressions	722	733	O
and	734	737	O
prognosis	738	747	O
in	748	750	O
esophageal	751	761	B-Pathological_formation
carcinoma	762	771	I-Pathological_formation
.	771	772	O

Forty	773	778	O
-	778	779	O
seven	779	784	O
specimens	785	794	O
resected	795	803	O
from	804	808	O
patients	809	817	B-Organism
with	818	822	O
stage	823	828	O
II	829	831	O
and	832	835	O
III	836	839	O
squamous	840	848	B-Pathological_formation
cell	849	853	I-Pathological_formation
carcinoma	854	863	I-Pathological_formation
(	864	865	O
SCC	865	868	B-Pathological_formation
)	868	869	O
of	870	872	O
the	873	876	O
esophagus	877	886	B-Organ
were	887	891	O
studied	892	899	O
using	900	905	O
immunohistochemical	906	925	O
staining	926	934	O
.	934	935	O

VEGF	936	940	B-Gene_or_gene_product
and	941	944	O
p53	945	948	B-Gene_or_gene_product
expressions	949	960	O
were	961	965	O
observed	966	974	O
in	975	977	O
40	978	980	O
%	980	981	O
and	982	985	O
53	986	988	O
%	988	989	O
of	990	992	O
the	993	996	O
tumors	997	1003	B-Pathological_formation
,	1003	1004	O
respectively	1005	1017	O
.	1017	1018	O

The	1019	1022	O
p53	1023	1026	B-Gene_or_gene_product
and	1027	1030	O
VEGF	1031	1035	B-Gene_or_gene_product
staining	1036	1044	O
statuses	1045	1053	O
were	1054	1058	O
coincident	1059	1069	O
in	1070	1072	O
only	1073	1077	O
21	1078	1080	O
%	1080	1081	O
of	1082	1084	O
the	1085	1088	O
tumors	1089	1095	B-Pathological_formation
,	1095	1096	O
and	1097	1100	O
no	1101	1103	O
significant	1104	1115	O
correlation	1116	1127	O
was	1128	1131	O
found	1132	1137	O
between	1138	1145	O
p53	1146	1149	B-Gene_or_gene_product
and	1150	1153	O
VEGF	1154	1158	B-Gene_or_gene_product
statuses	1159	1167	O
.	1167	1168	O

No	1169	1171	O
clinicopathologic	1172	1189	O
factors	1190	1197	O
were	1198	1202	O
significantly	1203	1216	O
correlated	1217	1227	O
with	1228	1232	O
p53	1233	1236	B-Gene_or_gene_product
or	1237	1239	O
VEGF	1240	1244	B-Gene_or_gene_product
expression	1245	1255	O
.	1255	1256	O

No	1257	1259	O
significant	1260	1271	O
association	1272	1283	O
between	1284	1291	O
p53	1292	1295	B-Gene_or_gene_product
and	1296	1299	O
VEGF	1300	1304	B-Gene_or_gene_product
expressions	1305	1316	O
and	1317	1320	O
poor	1321	1325	O
prognosis	1326	1335	O
was	1336	1339	O
found	1340	1345	O
.	1345	1346	O

In	1347	1349	O
conclusion	1350	1360	O
,	1360	1361	O
p53	1362	1365	B-Gene_or_gene_product
and	1366	1369	O
VEGF	1370	1374	B-Gene_or_gene_product
were	1375	1379	O
not	1380	1383	O
correlated	1384	1394	O
with	1395	1399	O
prognosis	1400	1409	O
in	1410	1412	O
patients	1413	1421	B-Organism
with	1422	1426	O
stage	1427	1432	O
II	1433	1435	O
and	1436	1439	O
III	1440	1443	O
SCC	1444	1447	B-Pathological_formation
of	1448	1450	O
the	1451	1454	O
esophagus	1455	1464	B-Organ
.	1464	1465	O

